MAIA Biotechnology (MAIA) Institutional Ownership

$2.94
+0.26 (+9.70%)
(As of 04/26/2024 ET)

Institutional Ownership Changes (13F Filings) for MAIA Biotechnology (NYSEAMERICAN:MAIA)

Current
Institutional Ownership
Percentage
5.65%
Number of
Institutional Buyers
(last 12 months)
2
Number of
Institutional Sellers
(last 12 months)
0
Get MAIA Insider Trade Alerts

Want to know when executives and insiders are buying or selling MAIA Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MAIA Biotechnology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/10/2023FNY Investment Advisers LLC17,550$38K0.0%N/A0.129%
7/20/2023 Naviter Wealth LLC22,168$49K0.0%N/A0.163%
2/7/2023Lynwood Capital Management Inc.250,000$878K1.1%+25.1%2.283%
1/4/2023Centric Wealth Management40,206$141K0.1%N/A0.367%
(Data available from 1/1/2016 forward)

MAIA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MAIA shares?

During the previous two years, the following institutional investors and hedge funds held shares of MAIA Biotechnology shares: Lynwood Capital Management Inc. ($878K), Centric Wealth Management ($141K), and Naviter Wealth LLC ($49K), FNY Investment Advisers LLC ($38K).Learn more on MAIA's institutional investors.

What percentage of MAIA Biotechnology stock is owned by institutional investors?

5.65% of MAIA Biotechnology stock is owned by institutional investors. Learn more on MAIA's institutional investor holdings.

Which institutional investors have been buying MAIA Biotechnology stock?

The following institutional investors have purchased MAIA Biotechnology stock in the last 24 months: Lynwood Capital Management Inc. ($50.22K), Centric Wealth Management ($40.21K), Naviter Wealth LLC ($22.17K), and FNY Investment Advisers LLC ($17.55K).

How much institutional buying is happening at MAIA Biotechnology?

Institutional investors have bought a total of 130,139 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions.


This page (NYSEAMERICAN:MAIA) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners